Intravenous injection of apelin-13 improves sensory-motor balance deficits caused by cerebral ischemic reperfusion injury in male wistar rats via restoration of nitric oxide
| Autor: | Nahid Aboutaleb, Raheleh Gholamzadeh, Donya Nazarinia |
|---|---|
| Rok vydání: | 2020 |
| Předmět: |
0301 basic medicine
Male Ischemia Nitric Oxide Neuroprotection Nitric oxide 03 medical and health sciences Cellular and Molecular Neuroscience chemistry.chemical_compound symbols.namesake 0302 clinical medicine Medicine Animals cardiovascular diseases Rats Wistar Stroke business.industry Infarction Middle Cerebral Artery Blood flow medicine.disease Apelin Rats Disease Models Animal 030104 developmental biology Neuroprotective Agents chemistry Motor Skills Anesthesia Reperfusion Injury Injections Intravenous cardiovascular system Nissl body symbols Intercellular Signaling Peptides and Proteins business Reperfusion injury 030217 neurology & neurosurgery |
| Zdroj: | Journal of chemical neuroanatomy. 112 |
| ISSN: | 1873-6300 |
| Popis: | It has been reported that apelin-13 possesses neuroprotective effects against cerebral ischemia/reperfusion injury (IRI). Disabilities in sense, movement and balance are the major stroke complications which, result in a high rate of mortality. Here, effects of intravenous (IV) injection of apelin-13 on the severity of neural death, infarct volume, neurological defects and its association with nitric oxide (NO) were investigated. A rat model of cerebral IRI was created by middle cerebral artery occlusion (MCAO) for 60 min and restoration of blood flow for 23 h. Animals were randomly assigned into six groups: sham, ischemia (MCAO), vehicle (MCAO + PBS) and three treatment groups (MCAO + apelin-13 in 10, 20, 40 μg/kg doses, IV). All injections were carried out via tail vein injection 5 min before reperfusion. Neural loss and infarct volume were evaluated by Nissl and 2,3,5-triphenyltetrazolium chloride (TTC) staining, respectively. Neurological defects were scored by standard modified criteria. Serum NO was measured by colorimetric method. Apelin-13 in doses of 20 and 40 μg/kg significantly reduced neural death, infarct volume and disturbance of sensory-motor balance compared to control and vehicle groups (p 0.05). Serum NO levels reduced in MCAO groups compared to sham. Apelin-13 restored serum NO levels at 20 μg/kg dose (p 0.05). Our data showed beneficial effect of IV injection of apelin-13 on sensory-motor balance defects by reducing neural death and restoration of serum NO levels. The present study shows the validity of apelin-13 in treatment of ischemic stroke in different administration methods. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full Text from ScienceDirect